E-cadherin expression in prostate cancer: A broad survey using high-density tissue microarray technology

Human Pathology

Volumn 32, Issue 7, 2001, Pages 690-697

  Rubin, Mark A ^a   Mucci, Neil R ^a   Figurski, Jay ^a   Fecko, Alice ^a   Pienta, Kenneth J ^a   Day, Mark L ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Adenocarcinoma; E cadherin; Immunohistochemistry; Prostate; Tissue microarray

Indexed keywords

ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; HORMONE; IMMUNOGLOBULIN G1; PROSTATE SPECIFIC ANTIGEN; UVOMORULIN;

ADULT; ARTICLE; CANCER HORMONE THERAPY; CANCER INVASION; CANCER LOCALIZATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EMBRYO; HISTOPATHOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NONHUMAN; PROSTATE CARCINOMA; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STAINING; TECHNOLOGY; TUMOR VOLUME;

EID: 0034897832     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.25902     Document Type: Article

References (40)

1. E-cadherin mediates aggregation-dependent survival of prostate and mammary epithelial cells through the retinoblastoma cell cycle control pathway
2. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas
3. Expression of immuno-reactive E-cadherin adhesion molecules in human cancers
4. Expression of E- and P-cadherin in gastric carcinomas
5. E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration
6. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathological features
7. Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis
8. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma
9. E-cadherin expression in renal cell cancer and its significance in metastasis and survival
10. Expression of E- and N-cadherin in renal cell carcinomas, in renal cell carcinoma cell lines in vitro and in their xenografts
11. Reduced expression of E-cadherin is related to invasive disease and frequent recurrence in bladder cancer
12. E-cadherin expression in papillary transitional cell carcinoma of the urinary bladder
13. Changes in E-cadherin immunoreactivity in the adenoma-carcinoma sequence of the large bowel
14. Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome
15. Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer
16. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells
17. Decreased expression of the intercellular adhesion molecule E-cadherin in prostate cancer: Biological significance and clinical implications
18. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer
19. Transcriptional regulation of the human E-cadherin gene in human prostate cancer cell lines: Characterization of the human E-cadherin gene promoter
20. E-cadherin: Expression of the epithelial cell-cell-adhesion molecule in prostatic carcinoma and normal prostate
21. Expression of cellular adhesion molecules on human prostate tumor cell lines
22. Expression of E-cadherin in primary and metastatic prostate cancer
23. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: Correlation with patient survival
24. Cadherin switching in human prostate cancer progression
25. E-cadherin expression as a marker of tumor aggressiveness in routinely processed radical prostatectomy specimens
26. Expression of E-cadherin in primary prostate cancer: Correlation with clinical features
27. Chromosome 16q24 deletion and decreased E-cadherin expression: Possible association with metastatic potential in prostate cancer
28. Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer
29. Co-ordinated changes in expression of cell adhesion molecules in prostate cancer
30. The cadherin cell-cell adhesion pathway in prostate cancer progression
31. Soluble forms of the adhesion molecule E-cadherin in urine
32. Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors
33. E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas
34. Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution
35. Rapid ("warm") autopsy study for procurement of metastatic prostate cancer
36. Classification of prostatic carcinomas
37. The TNM classification of prostate cancer
38. Neuroendocrine expression in metastatic prostate cancer: Evaluation of high throughput tissue microarrays to detect heterogeneous protein expression
39. Decreased expression of E-cadherin in the progression of rat prostatic cancer
40. N-cadherin expression in human prostate carcinoma cell lines. An epithelial-mesenchymal transformation mediating adhesion with Stromal cells